Flourish Research Announces Strategic Majority Investment from Genstar Capital

Investment to bolster leading multi-site clinical trial organization to further scale across therapeutic areas and geographies APEX, N.C. and SAN FRANCISCO, Sept. 18, 2024 /PRNewswire/ — Flourish Research (“Flourish” or the “Company”), an NMS Capital portfolio company and leading…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.